Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2025 09:56 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.

VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs Inc. (OTC: FITY), a leader in AI-powered healthcare and biotechnology solutions, is excited to announce the...
September 23, 2025 09:07 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB

VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc, (OTC:FITY) a Nevada-based holding company revolutionizing health, wellness, and biotech through...
August 26, 2025 09:18 ET | Source: Fifty 1 Labs, Inc.

Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032

VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has entered a groundbreaking partnership with LUNR...
August 14, 2025 08:30 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, Inc. (OTC: FITY), a leader in AI-powered drug repurposing and precision medicine, today announced the...
August 12, 2025 08:30 ET | Source: Fifty 1 Labs, Inc.

Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation

VANCOUVER, British Columbia and PALO ALTO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), together with its commercial partner...
July 29, 2025 09:00 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership

SEATTLE, July 29, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a pioneer in AI-powered health and wellness solutions, successfully hosted its virtual shareholder...
July 28, 2025 08:30 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières

SEATTLE, July 28, 2025 (GLOBE NEWSWIRE) -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in AI-powered health and wellness solutions, today announced it will host a virtual shareholder teleconference on...
July 17, 2025 08:55 ET | Source: Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies

SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), is thrilled to announce a strategic partnership with an intent...
July 10, 2025 08:56 ET | Source: Fifty 1 Labs, Inc.

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership

SEATTLE, July 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, a wholly owned subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), in collaboration with premier academic institutions including...
April 09, 2025 09:00 ET | Source: Fifty 1 Labs, Inc.

UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV

MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. (OTC: FITY), through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug...